Antibody full-length light chain reshapes variable domains aggregation without altering their dominance in amyloid fibrils

AL amyloidosis is a fatal systemic amyloid disease in which antibody light chains (LCs), including full-length (FL) and their proteolytically fragmented variable (VL) and constant (CL) domains, aggregate within a complex extracellular matrix (ECM) across multiple tissues. However, how these co-existing species shape aggregation kinetics, fibril morphology, stability, and toxicity remains unexplored. In this work, using a patient-derived LC (AL55), we show that FL transiently interacts with VL, slowing its aggregation nearly four-fold and diverting it into protease-sensitive, seeding-incompetent protofibrillar aggregates rather than mature amyloid assemblies. VL alone or in the presence of inert CL instead matures into toxic, protease-resistant, seeding-competent helical fibrils. Owing to their greater protease resistance and seeding competence, VL-dominated amyloid assemblies persist and contribute to their enrichment within tissues. The FL-mediated redirection is generic across multiple amyloidogenic VLs. These results reveal that LC aggregation, like that of Aβ and Tau, is governed by interplay between full-length and fragmented species, rather than VL domain aggregation in isolation. Overall, this work identifies a molecular basis for the selective enrichment of VL fibrils in patients and provides a therapeutic rationale for stabilizing VL domains to prevent their pathological aggregation.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.766878
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Antibody full-length light chain reshapes variable domains aggregation without altering their dominance in amyloid fibrils

Jogender Singh, Amit Kumawat, Sarita Puri, Annesha Ghosh et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Amyloidosis: Diagnosis, Treatment, Outcomes
preprint

Antibody full-length light chain reshapes variable domains aggregation without altering their dominance in amyloid fibrils

Jogender Singh, Amit Kumawat, Sarita Puri, Annesha Ghosh, Sharvari Palkar, Swasti Pradhan, Basudha Patel, Twinkle Aggarwal, Sandhya Gokula Nathan, Shivansh Singh, Saara Syam
preprint en

Abstract

AL amyloidosis is a fatal systemic amyloid disease in which antibody light chains (LCs), including full-length (FL) and their proteolytically fragmented variable (VL) and constant (CL) domains, aggregate within a complex extracellular matrix (ECM) across multiple tissues. However, how these co-existing species shape aggregation kinetics, fibril morphology, stability, and toxicity remains unexplored. In this work, using a patient-derived LC (AL55), we show that FL transiently interacts with VL, slowing its aggregation nearly four-fold and diverting it into protease-sensitive, seeding-incompetent protofibrillar aggregates rather than mature amyloid assemblies. VL alone or in the presence of inert CL instead matures into toxic, protease-resistant, seeding-competent helical fibrils. Owing to their greater protease resistance and seeding competence, VL-dominated amyloid assemblies persist and contribute to their enrichment within tissues. The FL-mediated redirection is generic across multiple amyloidogenic VLs. These results reveal that LC aggregation, like that of Aβ and Tau, is governed by interplay between full-length and fragmented species, rather than VL domain aggregation in isolation. Overall, this work identifies a molecular basis for the selective enrichment of VL fibrils in patients and provides a therapeutic rationale for stabilizing VL domains to prevent their pathological aggregation.

bioRxiv (Cold Spring Harbor Laboratory)
Indian Institute of Science Education and Research Mohali (IN), University of Cagliari (IT), Indian Institute of Science Education and Research Pune (IN)
Good health and well-being
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon